A copper-(I)-catalyzed variation of the Huisgen 1,3-dipolar cycloaddition has been applied to lead the in living-cell mass-spectrometry based identification of protein targets of oleocanthal, a natural metabolite daily ingested by millions of people. Chemical proteomics revealed heat-shock proteins, HSP70 and HSP90, as main oleocanthal interactors in living systems. These two proteins are involved in cancer development and, thus, our findings could have important outcomes for a deep evaluation of the bio-pharmacological significance of oleocanthal.
Beneficial health properties of the Mediterranean diet can be in large part attributed to the consumption of Extra Virgin Olive Oil (EVOO) [1] . Many small bioactive molecules have been identified in EVOO, many of which are phenolic compounds; the best known include tyrosol and hydroxytyrosol, and several studies have supported the positive effects of the EVOO phenolic fraction on oxidative plasma parameters and cellular functions, counteracting the development of chronic disease states [2a-d] . Indeed, the phenolic compounds extracted from EVOO are well-known to be involved in the reduction of colon cancer, cognitive disease and cardiovascular injury [3a-c] . In the last years, growing attention has moved to the biological effects of oleocanthal (OLC, Figure 1 ), an olive-oil phenolic component known to interfere with many pathways of relevant human diseases, such as neuro-degeneration, through interaction with tau protein and Aβ amyloids, and cancer by targeting HSP90, as recently reported by our research group [4a-c] . OLC was isolated from EVOO for the first time in 1993 by Montedoro et al. [5] , and discovered to be strictly connected to the typical throat pungent feeling, often experienced after ingestion of fresh EVOO [6] . Furthermore, a lot of interest was aroused when Beauchamp et al., in 2005 , reported a pharmacological correlation between the anti-inflammatory activity of ibuprofen and oleocanthal, which was capable of mimicking the cyclooxygenase inhibitory action of the NSAID [3a] .
Here, we complete our investigation of OLC, widening the identification of its interactome to a living cell system. Indeed, as already reported [7] , new techniques based on bio-orthogonal clickchemistry have been developed to determine the interactors of small-drugs in living cells, under physiologically appropriate settings. In this paper, we employed the copper-(I)-catalyzed variant of the Huisgen 1,3-dipolar cycloaddition, a simple reaction leading to a stable 1,2,3-triazole product through the reaction of azides and terminal alkynes [8] , to lead to the identification of the biochemical partners of OLC in living cells. Indeed, even though OLC reactive groups are here modified to obtain an opportunistic bait to fish out its partners, we are convinced that the recognition processes between the natural compound and its targets are still preserved since they are often based on non-covalent interactions, as previously reported by our research group [4c -7] . A typical in cell chemical proteomics process starts with the chemical decoration of the small molecule with an azide or a terminal alkyne, as appropriate functional groups for bio-orthogonal reactions. Then, cells are incubated with the tagged compound to allow its internalization and interactions with the most affine proteins. Furthermore, a mild cell lysis and addition of the suitable complementary reagents launch the click chemistry reaction, also allowing the connection of the small molecule to a solid support [7] . Isolation of this adduct is followed by washing and elution of the pulled-back proteins, subsequently separated by SDS-PAGE and identified by MS-based analysis [7] .
In our procedure, the appropriate OLC-derivative was arranged by coupling OLC with the 11-azido-3,6,9-trioxaundecan-1-amine (TRX-Az, Figure 2A ). The TRX-Az linker was chosen in place of an alkyne one to avoid any potential for in vivo alkyne reduction, likely due to the cellular reductase enzyme activity [9] , and also for its fine solubility in aqueous buffers and capability to cross cell membranes [10] . The product formation was monitored by RP-HPLC, MS and MS/MS analysis ( Figure 2B ). The reaction pathway, postulated on the basis of the MS results and our already published data [4a-c, 7] , goes through a Schiff base intermediate after reaction of the TRX-Az terminal amino group on an OLC aldehyde carbonyl, followed by a cyclization step evolving toward a piperidine-like product ( Figure 2B ). The OLC-TRX-Az derivative was then purified by RP-HPLC and lyophilized, with an approximately 90% yield. internalization amount was assessed after incubation of living cells with OLC-TRX-Az, cell lysis, RP-HPLC-MS/MS and integration of the peak area corresponding to the SRM transition ( Figure 3A and 3B). Thus, incubation with OLC-TRX-Az for 3 h at 100 µM gave 1% cell incorporation, and was chosen as the best condition for the following "fishing for partners" experiments.
In parallel, a sample of HeLa cells was treated with 100 µM of TRX-Az and submitted to the same procedure as used in the control experiment. After the incubation step, cells were washed with fresh buffer to remove the residual OLC-TRX-Az (or TRX-Az) and then lysed by gentle treatment with lysis buffer.
Lysates were then treated with the already reported catalytic mixture (100µM CuSO 4 , 5mM Na-L-(+)-ascorbate and 100 µM TBTA) [7] and PINA-bearing CDI-agarose beads for 1 h at 4°C to promote the Huisgen 1,3-cycloaddition (Figure 4 ). The identical reaction was also carried out without the presence of Na-L-(+)-ascorbate as a supplementary control. The pulled-down samples were then separated by SDS-PAGE, followed by both immuneblotting analysis and Comassie staining.
The immune-blotting was carried out using an antibody directed toward HSP90β, an already known target of OLC [4c]. Indeed, the in cell OLC interaction outline was compared with the one previously disclosed by the in vitro procedure [4c], to support its consistency. A clear enhancement of the HSP90β signal is observable in Figure 5A , accounting for the OLC affinity for this protein.
Finally, the gel bands excised out by both OLC-TRX-Az and control lanes were subjected to an in situ digestion protocol and the peptide mixtures were then analyzed through nano-flow LC-MS/MS, followed by Mascot database search for protein identification. The OLC-TRX-Az interactor list was refined by deleting the hits shared with the control experiments, thus obtaining a list of 5 proteins, as putative in cell targets of the molecule ( Figure  5B ). It is noteworthy that, on the basis of the Mascot score, the molecular chaperone HSP70 has been found as an OLC relevant partner together with HSP90, two interacting proteins within the cell metabolism. In conclusion, we have successfully applied an in cell pulldown LC-MS/MS methodology, based on the click-chemistry of the coppercatalyzed variant of the Huisgen 1,3-dipolar cycloaddition, for the interactome profiling of the olive-oil phenolic compound OLC. We obtained a list of cellular potential targets and, among them, HSP70 and HSP90 were selected as more relevant partners on the basis of the high confidential score obtained by bio-informatics tools. HSP70 and HSP90 are molecular chaperones that mainly assist protein cellular folding by their cooperative action, and have also been involved in cancer development. Moreover, recently, the role of both chaperones on the folding of tau, a neurological diseaseassociated protein has been reported [11a-b] . Since also OLC acts on the tau oligomerization state [4a-b] , it could be relevant to analyze deeply the effect of this compound on the HSP90-HSP70-tau ternary system. Therefore, our findings could have important outcomes in future applications for a deep evaluation of the biopharmacological significance of OLC. 
Experimental
Design and synthesis of OLC-TRX-Az: OLC (1.5 mM) was coupled with 11-azido-3,6,9-trioxaundecan-1-amine (TRX-Az, 15 mM) in ACN at 0.5% TEA for 1 h at 25°C with stirring. Then, 10 μL of 100 mM NaBH 4 was added for 30 min. at r.t. Product formation was monitored by RP-HPLC-UV at 220 nm using an Agilent 1100 binary pump and a Phenomenex column (Jupiter C18 150X2 mm 5 µ) at 0.2 mL/min. Gradient was from 5% to 95% buffer B (A= 100% H 2 O and 0.1% TFA and B= 95% ACN, 5% H 2 O and 0.1% TFA) in 25 min. Mass spectra were acquired on a LCQ-DECA Thermo-Finnigan spectrometer equipped with an ESI source.
Internalization of OLC-TRX-Az: OLC-TRX-Az solutions for a calibration curve were prepared by diluting the molecule in H 2 O:ACN buffer at concentrations ranging from 10 nM to 100 µM. Each sample was loaded onto a HPLC-MS system LTQ XL ThermoScientific equipped with Accelera 600 Pump and AcceleraAuto-Sampler system. Chromatographic separation was carried out on a Phenomenex C18 column (250X2.0 mm) by means of a linear gradient from 5-95%acetonitrile in 2% formic acid and 0.1% TFA. Mass spectra were acquired in the m/z interval of 1-1000.The estimation of OLC-TRX-Az was estimated using the same LCMS procedure. Thus, OLC-TRX-Az was incubated in HeLa cells at different concentrations from 1 µM to 100 µM for 3 h and both supernatants and cell lysates were chromatographed as reported above. Before injecting cell lysates, protein precipitation was achieved in acetone at 4°C for 3 h and centrifuged at 16000 rpm for 3 h. The supernatants were dried and re-suspended in H 2 O/ACN.
In-situ proteome profiling: OLC-TRX-Az (100 µM) was incubated in HeLa cells for 3 h at 4°C and then mixed with 50 µL of CDIAgarose matrix bearing PINA linker in the presence of CuSO 4 , Na-L-(+)-ascorbate and TBTA under nitrogen for 45 min at room temperature. As control, the experiment was carried out under the same conditions using the TRX-Az as bait. After several washes in PBS buffer to remove the unbound proteins, OLC partners were eluted using a denaturant buffer (Tris 100 mM, SDS 4%, glycerol 20%, β-mercaptoethanol at 200 mM), boiling the sample for 5 min, separated by 12% SDS-PAGE and transferred onto a nitrocellulose membrane. The membrane was incubated for 1 h in a blocking solution containing 25 mM Tris, pH 8, 125 mM NaCl, 0.1% Tween-20, and 5% nonfat dried milk prior to overnight incubation, at 4°C, with a primary monoclonal antibody raised against HSP90β (1:500). Then, the membrane was incubated for 1 h with an anti-rabbit peroxidase-conjugated secondary antibody (1:5000). HSP90β was detected by a chemo-luminescence detection system.
Large-scale pull-down/LC-MS/MS analysis:
Live HeLa cells were grown as described above, treated with 100 µM of OLC-TRXAzand 100 µM of TRX-Az for 3 h and then washed with fresh media to remove the excess of drug which did not pass through cell membranes. Cells were then lysed by PBS containing 0.1% IGEPAL and protease inhibitors by Dounce manual homogenator. One mg of lysates was then treated with 100 µM CuSO 4 , 5 mM Na-L-(+)-ascorbate and 100 µM TBTA under nitrogen to promote Huisgen 1,3 cycloaddition on 10 µL of PINA derived CDI-agarose beads for 45 min at room temperature. The same reaction was carried out both on the same sample without 5 mM Na-L-(+)-Ascorbate and on TRX-Az treated cell lysates as negative controls. Pull-down samples were then separated by SDS-PAGE followed both by immune-blotting analysis, as described above, and Comassie staining. SDS-PAGE gel lanes were cut and digested as reported by Shevchenko et al. [12] . Briefly, each slice was reduced with 10 mM 1,4-dithiothreitol (DTT) and alkylated with 54 mM iodoacetamide, then washed and rehydrated in trypsin solution (12 ng/mL) on ice for 1 h. After the addition of ammonium bicarbonate (30 µL, 50 mM, pH 7.5), protein digestion was allowed to proceed overnight at 37°C. The supernatant was collected and peptides were extracted from the slice using 100% CH 3 CN and both supernatants were combined. The peptide sample was dried and dissolved in formic acid (FA, 10%) before MS analysis. The peptide mixture (5 μL) was injected into a nano-ACQUITY UPLC system (Waters 
